1. Home
  2. KNSA vs SPNS Comparison

KNSA vs SPNS Comparison

Compare KNSA & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • SPNS
  • Stock Information
  • Founded
  • KNSA 2015
  • SPNS 1982
  • Country
  • KNSA United Kingdom
  • SPNS Israel
  • Employees
  • KNSA N/A
  • SPNS N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • SPNS Computer Software: Prepackaged Software
  • Sector
  • KNSA Health Care
  • SPNS Technology
  • Exchange
  • KNSA Nasdaq
  • SPNS Nasdaq
  • Market Cap
  • KNSA 1.7B
  • SPNS 1.9B
  • IPO Year
  • KNSA 2018
  • SPNS 1992
  • Fundamental
  • Price
  • KNSA $21.09
  • SPNS $27.55
  • Analyst Decision
  • KNSA Strong Buy
  • SPNS Buy
  • Analyst Count
  • KNSA 5
  • SPNS 3
  • Target Price
  • KNSA $36.60
  • SPNS $36.00
  • AVG Volume (30 Days)
  • KNSA 365.7K
  • SPNS 180.9K
  • Earning Date
  • KNSA 10-29-2024
  • SPNS 11-11-2024
  • Dividend Yield
  • KNSA N/A
  • SPNS 2.06%
  • EPS Growth
  • KNSA N/A
  • SPNS 19.80
  • EPS
  • KNSA N/A
  • SPNS 1.27
  • Revenue
  • KNSA $384,098,000.00
  • SPNS $538,933,000.00
  • Revenue This Year
  • KNSA $60.05
  • SPNS $9.55
  • Revenue Next Year
  • KNSA $36.32
  • SPNS $7.07
  • P/E Ratio
  • KNSA N/A
  • SPNS $21.35
  • Revenue Growth
  • KNSA 54.41
  • SPNS 7.10
  • 52 Week Low
  • KNSA $15.52
  • SPNS $25.30
  • 52 Week High
  • KNSA $28.15
  • SPNS $41.22
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 34.36
  • SPNS 26.37
  • Support Level
  • KNSA $20.41
  • SPNS $26.82
  • Resistance Level
  • KNSA $21.55
  • SPNS $28.74
  • Average True Range (ATR)
  • KNSA 0.87
  • SPNS 0.96
  • MACD
  • KNSA -0.14
  • SPNS -0.81
  • Stochastic Oscillator
  • KNSA 21.90
  • SPNS 5.54

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Share on Social Networks: